**Correction to:** *Molecular Psychiatry* advance online publication, 8 December 2015; doi:[10.1038/mp.2015.178](/doifinder/10.1038/mp.2015.178)

Following publication of this paper, the authors noticed that [Figures 5a and b](#fig5){ref-type="fig"} contained the same image. In addition, there was a typo in [Table 3](#tbl3){ref-type="table"} at \#703. The correct figure and table appear here.

![(**a**--**d**) Efficacy outcomes in means over time.](mp2016140f5){#fig5}

###### Baseline biomarker levels and the probability of response to NSI-189 at day 28

  *Patient. ID*   *Designation*   *Probablilty*
  --------------- --------------- ---------------
  501             PR              1.000
  502             R               1.000
  504             R               1.000
  505             R               1.000
  506             R               1.000
  508             NR              0.032
  602             R               1.000
  603             R               0.961
  604             PR              1.000
  606             PR              0.998
  608\*           PR\*            0.000\*
  627             R               0.980
  701             R               1.000
  702             R               0.987
  703             NR              0.000
  705             NR              0.031
  706             R               1.000
  707             R               0.995

Abbreviations: A1AT, alpha-1-antitrypsin; BNF, brain-derived neurotrophic factor; EGF, epidermal growth factor; MADRS, montgomery-asberg depression scale; MPO, myeloperoxidase; NR, non-responder; PR, partial responder; R, responder; TNFR2, tumor necrosis factor receptor type 2. Indicates the individual patient identifier, and the response group designation (R, PR and NR) and the predicted probability of response based upon analysis of baseline biomarker data. We used partial least squares discriminant analysis to choose the important variables (BDNF, EGF, MPO, TNFR2 and A1AT) in predicting response. One possible outlier (\*) was patient 608 who was designated a partial responder based on a single MADRS score of 16 which indicated a change from moderate to mild depression. The observed probability was consistent with the patient being a NR.
